2013-08-21 14:12:51 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to AEterna Zentaris Inc. (USA) (AEZS) and produced a report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering AEterna Zentaris Inc. (USA) (AEZS). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential AEterna Zentaris Inc. (USA) investor.
Report Summary: AEterna Zentaris Inc. (USA) is a low quality company with a positive outlook. AEterna Zentaris Inc. (USA) has weak business growth and is run by passable management. The trend in AEterna Zentaris Inc. (USA) fair value exchange rate against its closest rated-competitor, Transcept Pharmaceuticals Inc, has been depreciating over the past 2 weeks. When compared to its closest competitor, AEterna Zentaris Inc. (USA) shows similar overvaluation and is equally likely to underperform the market.
The report breaks down
the Total StockMark into its three components - business, management and price, performing an in-depth analysis of AEterna Zentaris Inc. (USA) for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, West Services, Advisen, Alacra-Datadownlink, Factiva, INTERNET SECURITIES and LEXIS/NEXIS or directly from SADIF-Investment Analytics at:
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering sixteen different markets and over 20,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.